The Effects of Kinesio Taping in Women With Primary Dysmenorrhea

Assistant Professor, Physioterapist, PhD

The aim of our study was to investigate the effects of kinesio taping in women with primary dysmenorrhea.

Study Overview

• Status: Unknown
• Conditions: Primary Dysmenorrhea
• Intervention / Treatment: Other: Kinesio tape application; Other: Sham Kinesio tape application; Other: No intervention

• Study Type: Interventional
• Enrollment (Anticipated): 60
• Phase: Not Applicable

Contacts and Locations

• Study Contact: Name: Basak KAVALCI; Phone Number: +90-552-227-02-94; Email: kavalcibasak@gmail.com

Study Locations

• Turkey
  • Ankara, Turkey
    • Recruiting
    • Ankara Yildirim Beyazit University
    • Contact: Aysenur Karakus

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 16 years to 33 years (Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: Female

Description

Inclusion Criteria:

• 18 to 35 years of age,
• having Primary Dysmenorrhea
• being volunteer women

Exclusion Criteria:

• having give birth,
• having a serious psychiatric disorder
• having used oral contraceptive or depression drug in the last 6 month
• having secondary dysmenorrhea
• having irregular menstrual cycle
• having allergy to taping

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Treatment
• Allocation: Randomized
• Interventional Model: Factorial Assignment
• Masking: Single

Number of Arms

3

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: Kinesio tape group; Kinesio tape application has been applied	Other: Kinesio tape application; Kinesio tape application will be performed.Taping is carried out from the estimated day of ovulation (cycle length in days minus 14) until the next menstrual period begins
Sham Comparator: Sham group; Sham kinesio tape application has been applied	Other: Sham Kinesio tape application; Sham kinesio tape application will be performed. Sham taping is carried out from the estimated day of ovulation (cycle length in days minus 14) until the next menstrual period begins
Other: Control group; No intervention has been applied	Other: No intervention; The natural process will be followed from the estimated day of ovulation (cycle length in days minus 14) until the next menstrual period begins

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
The severity of menstrual pain assessed with Visual Analog Scale	A 10-cm Visual Analog Scale anchored from zero (no pain at all) to 10 (the worst pain I have ever felt) was used to determine the severity of each subject's menstrual pain.	An average of 2 weeks

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
The complaints related to menstruation will be evaluated by a form prepared by the researchers	The form assessing the complaints related to menstruation will be evaluated existing complaints affect the patient and expressed as, no, little, mederate, very.	An average of 2 weeks
The level of anxiety will be evaluated with The Spielberger State Trait Anxiety Inventory	The Spielberger State Trait Anxiety Inventory is a 40-item self-report inventory designed to measure both state anxiety section (current feelings of apprehension, worry, etc.) and trait anxiety section (continuous feelings of apprehension, worry, etc.). Each section is scored on four levels of anxiety intensity from 1="not at all" to 4="very much" and with a sum score between 20 and 80. A higher total score indicates more severe anxiety level.	An average of 2 weeks

Collaborators and Investigators

• Sponsor: Ataturk Training and Research Hospital
• Investigators: Study Chair: Basak Kavalci, Gümüşhane Universıty; Study Chair: Aysenur Karakus, Ankara Yildirim Beyazıt University

Study record dates

Study Major Dates

• Study Start (Actual): March 10, 2019
• Primary Completion (Anticipated): June 1, 2019
• Study Completion (Anticipated): September 1, 2019

Study Registration Dates

• First Submitted: April 10, 2019
• First Submitted That Met QC Criteria: April 12, 2019
• First Posted (Actual): April 16, 2019

Study Record Updates

• Last Update Posted (Actual): April 16, 2019
• Last Update Submitted That Met QC Criteria: April 12, 2019
• Last Verified: April 1, 2019

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Pathologic Processes; Pain; Neurologic Manifestations; Menstruation Disturbances; Pelvic Pain; Dysmenorrhea
• Other Study ID Numbers: 442-15

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No